The Effects of r-metHuIFN-Gamma on the Lungs of Patients With AIDS

Launched by AMGEN · Aug 30, 2001

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• • Inclusion Criteria
• Patients must have:
• • Diagnosis of AIDS with one or more opportunistic infections.
• • Kaposi's sarcoma with prior history of opportunistic infection.
• • Stable dose of zidovudine (AZT) therapy.
• • Preserved pulmonary, renal and hepatic function.
• • Exclusion Criteria
• Co-existing Condition:
• Patients with the following conditions or symptoms are excluded:
• • Presence of active infection.
• • Active opportunistic infections.
• • Cardiac disease.
• • Central nervous system disorders.
• • History of seizures.
• • Irreversible airway disease.
• Patients with the following are excluded:
• • Co-existing conditions and symptoms listed in Patient Exclusion Co-existing Conditions.
• Prior Medication:
• Excluded within 4 weeks of study entry:
• • Immunosuppressive therapy.
• • Cytotoxic therapy.
• * Excluded:
• • Interferon gamma therapy.